• Aligning CMC, clinical, and regulatory strategies in early- to mid-stage development
• Navigating the transition from Phase 1/2 to pivotal trials and commercial planning
• Building a manufacturing strategy that adapts to growth and complexity
• Leveraging external partnerships while building internal capabilities
• Avoiding common pitfalls during the clinical-to-commercial shift